Perbedaan Pradiksi Gunatama Tbk. dan Organon Pharma Indonesia Tbk.: Pradiksi Gunatama Tbk. diperdagangkan di Rp9.600 (kapitalisasi pasar 55,94 T, volume 24 jam 15,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pradiksi Gunatama Tbk. jauh lebih besar — sekitar 535,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PGUN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 55,94 T | 104,4 M |
Volume | 15,3 rb | — |
Lot | 153 | — |
Perputaran | 146,97 jt | — |
Harga Rata-rata | 9.605,56 | — |
Nilai Transaksi | 146,97 jt | — |
Harga Ekuilibrium Indikatif | 9.600 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Pradiksi Gunatama Tbk (Company), was established on September 11, 1995 in the Republic of Indonesia in the framework of foreign investment in accordance with the Domestic Investment Law No. 1 of 1989, Juncto Law No. 12 of 1970, based on deed No. 46 dated June 21, 1996 notary Ny. Toety Juniarto.SH in Jakarta. The Company commenced commercial operations in 2002.
Selengkapnya di halaman PGUN →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →